Your Health & Safety Is Important to Us: Learn More Here

August 16 - 18, 2020 | Las Vegas

John McCamant

speaker photo BIOTECH

Editor

Medical Technology Stock Letter

John McCamant joined the Medical Technology Stock Letter as associate editor in 1987 and was named editor of this leading investment newsletter in August 2000. He has spent 25 years on the front lines of biotechnology investing. As an equities analyst for the American Healthcare Fund, Mr. McCamant uncovered investment opportunities and guided investment strategy. At Burrill & Company, a San Francisco-based private merchant bank, he was a lead in raising $75 million for a venture capital fund. Mr. McCamant has established an extensive network that includes contacts throughout the investment banking and venture capital communities. His expertise in biotechnology investments is a subject of media interest, and he is frequently consulted and quoted by The Washington Post, BusinessWeek, Reuters, Bloomberg, and Marketwatch.

Speaker Schedule

Profiting from the Next Wave in Tech & Biotech*
August 16, 2020, 3:30 pm - 5:30 pm

Focus: TECHNOLOGY

MASTER CLASS

Biotech Investing Post-Covid-19 Pandemic
August 17, 2020, 2:30 pm - 2:50 pm

Focus: BIOTECH

Ready to #InvestSmarter?

We’ve limited attendance at The MoneyShow Las Vegas in order to allow you to stay at a safe social distance from your peers. However, your paid attendance now packs much more value into your conference experience with classroom seating, coffee, and more!

Register Now